https://www.epmmagazine.com/topics/drug_discovery/index.rss en-gb © 2020 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved. Wed, 22 Jul 2020 14:05:00 -0000 Ian Bolland Ian Bolland speaks to Epistemic AI founders Stefano Pacifico and David Heeger about how its software can be used in drug development and the race to find a cure for Coronavirus. https://www.epmmagazine.com/opinion/q-a-epistemic-ai-drug-discovery/ https://www.epmmagazine.com/opinion/q-a-epistemic-ai-drug-discovery/ Wed, 22 Jul 2020 14:05:00 -0000 AI Sygnature Discovery, an integrated drug discovery and pre-clinical services provider has acquired Alderley Oncology to strengthen its oncology and immuno-oncology capabilities. https://www.epmmagazine.com/news/sygnature-discovery/ https://www.epmmagazine.com/news/sygnature-discovery/ Thu, 04 Jun 2020 10:15:00 -0000 acquisition A UK-based AI start-up has made its drug discovery tool available to scientists to help support biomedical research. https://www.epmmagazine.com/news/UK-start-up-makes-drug/ https://www.epmmagazine.com/news/UK-start-up-makes-drug/ Wed, 27 May 2020 10:35:00 -0000 Drug Discovery Lu Rahman The role AI can play in drug discovery and development is well documented, but the recent global pandemic has highlighted the growing importance this technology has in the fight against disease, writes Lu Rahman. https://www.epmmagazine.com/opinion/why-we-need-to-take-ai-in-drug-discovery-seriously/ https://www.epmmagazine.com/opinion/why-we-need-to-take-ai-in-drug-discovery-seriously/ Wed, 20 May 2020 10:10:08 -0000 AI The Medicines Discovery Catapult has announced a new collaboration to improve our understanding of the cellular mechanisms of infection by Covid-19. https://www.epmmagazine.com/news/medicines-discovery-catapult-teams-up-to-understand-cellular/ https://www.epmmagazine.com/news/medicines-discovery-catapult-teams-up-to-understand-cellular/ Mon, 27 Apr 2020 09:05:00 -0000 Covid Cells Japanese technology company Fujitsu has partnered with biotechnology company Polarisqb to test a new drug discovery platform designed to help pharmaceutical companies accelerate medicines to market. https://www.epmmagazine.com/news/fujitsu/ https://www.epmmagazine.com/news/fujitsu/ Wed, 25 Mar 2020 11:05:00 -0000 Drug Discovery Giulia Ossato Giulia Ossato, product manager, Confocal, Leica Microsystems discusses how advances in imaging techniques could improve drug discovery research. https://www.epmmagazine.com/opinion/how-imaging-advances-could-accelerate-drug-discovery/ https://www.epmmagazine.com/opinion/how-imaging-advances-could-accelerate-drug-discovery/ Mon, 02 Mar 2020 12:20:00 -0000 Drug Discovery A new project has been announced to improve imaging technology for cancer drug discovery. https://www.epmmagazine.com/news/drug-discovery-project/ https://www.epmmagazine.com/news/drug-discovery-project/ Mon, 02 Mar 2020 11:35:00 -0000 Drug Discovery A spin-out from the University of Edinburgh will investigate new treatments for multiple sclerosis (MS) that could reverse the effects of the disease. https://www.epmmagazine.com/news/edinburgh-spin-out-targets-new-drugs-for-ms/ https://www.epmmagazine.com/news/edinburgh-spin-out-targets-new-drugs-for-ms/ Tue, 18 Feb 2020 11:40:00 -0000 Multiple Sclerosis Biotechnology companies Aptamer Group and Valitacell are working together to develop a next-generation screening platform for drug development, the companies have announced. https://www.epmmagazine.com/news/aptamer-group-and-valitacell-to-develop-new-drug-discovery-p/ https://www.epmmagazine.com/news/aptamer-group-and-valitacell-to-develop-new-drug-discovery-p/ Fri, 03 Jan 2020 11:40:00 -0000 Drug discovery The European Laboratory Research & Innovation group (ELRIG) UK and the British Pharmacological Society have announced a strategic alliance to drive the development of new medicines in the UK. https://www.epmmagazine.com/news/strategic-alliance-aims-to-improve-uk-drug-discovery/ https://www.epmmagazine.com/news/strategic-alliance-aims-to-improve-uk-drug-discovery/ Tue, 17 Dec 2019 11:15:00 -0000 Medicines SMi Reports: Registration is open for SMi’s inaugural AI in Drug Discovery conference taking place in London in March 2020. https://www.epmmagazine.com/news/registration-opens-for-smis-ai-in-drug-discovery-conference/ https://www.epmmagazine.com/news/registration-opens-for-smis-ai-in-drug-discovery-conference/ Wed, 20 Nov 2019 15:50:00 -0000 AI Charlotte Walker-Osborn Nabil Asaad The rise of artificial intelligence has been popular within the life sciences industry and in particular pharma. Find out why and what it means for the future of drug development. https://www.epmmagazine.com/analysis/ais-impact-on-the-future-of-pharma-and-drug-discovery/ https://www.epmmagazine.com/analysis/ais-impact-on-the-future-of-pharma-and-drug-discovery/ Tue, 17 Sep 2019 14:58:21 -0000 ai chip.jpg UK drug discovery researchers will soon be able to use artificial intelligence (AI) to support their projects thanks to a partnership between Medicines Discovery Catapult and the online platform Chief.AI. https://www.epmmagazine.com/news/new-partnership-set-to-provide-ai-for-uk-drug-discovery-mark/ https://www.epmmagazine.com/news/new-partnership-set-to-provide-ai-for-uk-drug-discovery-mark/ Mon, 13 May 2019 08:51:55 -0000 AI Medicines Discovery Catapult has announced 22 new partnership with UK contract research organisations (CROs) in an aim to boost the UK’s international competitiveness across life sciences research and development (R&D). https://www.epmmagazine.com/news/medicines-discovery-catapult/ https://www.epmmagazine.com/news/medicines-discovery-catapult/ Fri, 26 Apr 2019 08:56:12 -0000 Research UK SMEs will be able to access collaborative research programmes thanks to a new partnership between Medicines Discovery Catapult and Alderley Park. https://www.epmmagazine.com/news/medicines-discovery-catapult-alderely-park-team-up/ https://www.epmmagazine.com/news/medicines-discovery-catapult-alderely-park-team-up/ Tue, 09 Apr 2019 10:05:13 -0000 Drug discovery Global pharma player Lundbeck has announced a project with information analytics company Elsevier to help it improve the way it manages data and ultimately speed up drug development. https://www.epmmagazine.com/news/lundbeck/ https://www.epmmagazine.com/news/lundbeck/ Tue, 26 Feb 2019 11:35:00 -0000 Data CytoReason has entered into a collaboration agreement with Pfizer over its machine learning model for drug discovery. https://www.epmmagazine.com/news/cytoreason-and-pfizer-enter-collaboration-over-drug-discover/ https://www.epmmagazine.com/news/cytoreason-and-pfizer-enter-collaboration-over-drug-discover/ Tue, 08 Jan 2019 14:48:00 -0000 pfizer.jpg A new strategic collaboration is aiming to reduce the use of animals in research whilst also accelerating the translation of more research models in drug discovery. https://www.epmmagazine.com/news/strategic-collaborations-aims-to-reduce-the-use-of-animals-i/ https://www.epmmagazine.com/news/strategic-collaborations-aims-to-reduce-the-use-of-animals-i/ Mon, 12 Nov 2018 09:15:00 -0000 Animal research A two-year strategic research collaboration and licence agreement has been formed between Karolinska Institute spin out, Pelago Bioscience, and Vertex Pharmaceuticals that will focus on the CETSA method. https://www.epmmagazine.com/news/two-year-strategic-collaboration-focuses-on-cetsa-method/ https://www.epmmagazine.com/news/two-year-strategic-collaboration-focuses-on-cetsa-method/ Mon, 10 Sep 2018 11:39:03 -0000 Partnership Preclinical stage drug discovery company, CYTOO, and biopharmaceutical company, Pfizer, have announced a research collaboration with the aim of developing a target discovery platform for Duchenne Muscular Dystrophy (DMD). https://www.epmmagazine.com/news/cytoo-and-pfizer-join-forces-for-dmd-discovery-platform/ https://www.epmmagazine.com/news/cytoo-and-pfizer-join-forces-for-dmd-discovery-platform/ Fri, 07 Sep 2018 10:57:15 -0000 partnership Newly formed drug discovery company, Azeria Therapeutics, has announced that it has successfully raised £4 million in a Series A investment round from the £70 million CRT Pioneer Fund, managed by Sixth Element Capital. https://www.epmmagazine.com/news/azeria-therapeutics-successful-raises-4-million/ https://www.epmmagazine.com/news/azeria-therapeutics-successful-raises-4-million/ Tue, 04 Sep 2018 11:45:39 -0000 funding Dr Sheuli Porkess Here, Dr Sheuli Porkess, deputy chief scientific officer, Association of the British Pharmaceutical Industry (ABPI), outlines how the pharmaceutical industry takes a substance from molecule to medicine and how the process requires persistence. https://www.epmmagazine.com/opinion/from-molecule-to-medicine-the-importance-of-persistence/ https://www.epmmagazine.com/opinion/from-molecule-to-medicine-the-importance-of-persistence/ Mon, 20 Aug 2018 11:15:40 -0000 Medicine Ubiquigent — a company focused on enabling and supporting ubiquitin system targeted drug discovery — has been awarded a new grant from Innovate UK. https://www.epmmagazine.com/news/ubiquigent-receives-grant-from-innovate-uk/ https://www.epmmagazine.com/news/ubiquigent-receives-grant-from-innovate-uk/ Thu, 16 Aug 2018 11:06:11 -0000 Investment Global drug discovery and development services company, Crown Bioscience, has extended its existing portfolio of humanised drug target models (HuGEMM) to its San Diego facility. https://www.epmmagazine.com/news/crown-bio-extends-portfolio-of-hugemm-to-san-diego/ https://www.epmmagazine.com/news/crown-bio-extends-portfolio-of-hugemm-to-san-diego/ Mon, 30 Jul 2018 12:55:12 -0000 San Diego According to scientists from the Medical Research Council (MRC) Laboratory of Molecular Biology in Cambridge, UK, a new drug discovery system can be used to target phosphatases (a family of enzymes) that are mostly considered to be ‘undruggable’. https://www.epmmagazine.com/news/new-drug-discovery-system-can-target-undruggable-enzymes/ https://www.epmmagazine.com/news/new-drug-discovery-system-can-target-undruggable-enzymes/ Fri, 27 Jul 2018 12:23:57 -0000 Neurons A strategic partnership has been formed between Taconic Biosciences and Cyagen Biosciences — both global companies that generate custom genetically engineered rodent models and associated services. https://www.epmmagazine.com/news/strategic-partnership-forms-between-taconic-and-cyagen/ https://www.epmmagazine.com/news/strategic-partnership-forms-between-taconic-and-cyagen/ Tue, 24 Jul 2018 09:34:13 -0000 Strategic alliance Concept Life Sciences — integrated drug discovery, development and analytical services company — has achieved FDA Establishment Identifier (FEI) registration and commissioned an expansion of its services as a result. https://www.epmmagazine.com/news/concept-to-expand-services-as-a-result-of-successful-fei-registration/ https://www.epmmagazine.com/news/concept-to-expand-services-as-a-result-of-successful-fei-registration/ Mon, 16 Jul 2018 11:51:34 -0000 Business growth Integrated solutions provider — Lonza — has announced the launch of a new bioscience website, designed to support the work of scientists across the bioresearch, drug discovery and pharmaceutical manufacturing fields. https://www.epmmagazine.com/technology/lonza-launches-new-dedicated-bioscience-website/ https://www.epmmagazine.com/technology/lonza-launches-new-dedicated-bioscience-website/ Wed, 04 Jul 2018 10:31:31 -0000 Website launch Provider of integrated drug discovery services, BioAscent Discovery, has secured funding worth £1.6 million from Maven Capital Partners, which it will use for growth through its offering of integrated drug discovery and compound management services. https://www.epmmagazine.com/news/bioascent-discovery-secures-funding-for-growth/ https://www.epmmagazine.com/news/bioascent-discovery-secures-funding-for-growth/ Thu, 28 Jun 2018 10:56:24 -0000 funding